Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson (Q36797240)
Jump to navigation
Jump to search
scientific article published on February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson |
scientific article published on February 2013 |
Statements
1 reference
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson (English)
1 reference
Donna Neuberg
1 reference
Joshua J Field
1 reference
Gene Lin
1 reference
Maureen M Okam
1 reference
Elaine Majerus
1 reference
Jeffrey Keefer
1 reference
Onyinye Onyekwere
1 reference
Ainsley Ross
1 reference
Federico Campigotto
1 reference
Joel Linden
1 reference
David G Nathan
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference